IXJ
Equity

iShares Global Healthcare ETF

NAV as ofMay 15, 2026
$91.9352 WK: 82.77 - 101.84
1 Day NAV Change as ofMay 15, 2026
Decrease $-1.01(-1.08%)
May 14, 2026
YTD: Decrease -4.48%
Apr 30, 2026
1.57%
Apr 30, 2026
1.46%
Expense Ratio:Fees as stated in the prospectus
0.40%
4 stars
Bronze Medal
NAV as ofMay 15, 2026
$91.9352 WK: 82.77 - 101.84
1 Day NAV Change as ofMay 15, 2026
Decrease $-1.01(-1.08%)
May 14, 2026
YTD: Decrease -4.48%
Apr 30, 2026
1.57%
Apr 30, 2026
1.46%
Expense Ratio:Fees as stated in the prospectus
0.40%
4 stars
Bronze Medal

Important Notice Regarding a Change in Underlying Index – The Board of Trustees of iShares Trust has approved a change to the Underlying Index for the iShares Global Healthcare ETF (NYSE: IXJ) that is expected to take effect on or about March 23, 2026. On such date, the fund will seek to track a new underlying index, S&P Global 1200 Health Care™ (Sector) Capped Index, and will cease to track the S&P Global 1200 Health Care™ Index. For more information, please contact 1-800-iShares (474-2737).

The iShares Global Healthcare ETF seeks to track an index composed of global equities in the healthcare sector. The fund can be used to express a global sector view and gain diversified access to pharmaceutical, biotech, and medical device companies worldwide.

Key Facts

Net Assets of Fund
Fund Inception
Exchange
NYSE Arca
Shares Outstanding
38,900,000
as of May 15, 2026
0.04
as of May 15, 2026
Closing Price
91.97
as of May 15, 2026
116,772.00
as of May 15, 2026
173,473.00
as of May 15, 2026
Asset Class
Equity
Semi-Annual
CUSIP
464287325
92.08
as of May 15, 2026
0.12%
as of May 15, 2026

Portfolio Characteristics

13.38%
as of Apr 30, 2026
3.85
as of May 14, 2026
0.50
as of Apr 30, 2026
23.92
as of May 14, 2026

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section.

More Funds to Consider

IYH
iShares U.S. Healthcare ETFView IYH
IHE
iShares U.S. Pharmaceuticals ETFView IHE

Holdings

Holdings are subject to change.


The values shown for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Holdings data shown reflects the investment book of record, which may differ from the accounting book of record used for the purposes of determining the Net Assets of the Fund. Notional value represents the portfolio's exposures based on the economic value of investments and options are delta-adjusted. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The calculated values may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent date for which a price is available and may not necessarily be as of the date shown above.

Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures.

“Quantity” represents the number of shares, units or contracts of the corresponding security, as applicable per security type.